- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 293M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $203.56M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $204.55M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $985K |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $1.73M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $29.25M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $26.38M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $77.29M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $78.53M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $435.63M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $430.41M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $101.2M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $104.43M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $600.73M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $607.23M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 290.62M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.8M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $13.25M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $232.11M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $240.74M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$14.85M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $6.07M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $38.73M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $41.9M |
| Revenue | Q1 2025 · Mar 31, 2024 | $80.63M |